Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubinuclein 1 pseudogene (ENSG00000224054) is a genomic locus classified as a processed pseudogene, meaning it is a nonfunctional DNA segment that closely resembles the functional gene "ubinuclein 1" but cannot produce a functional protein. Pseudogenes are often formed by gene duplication or retrotransposition, resulting in copies of genes that lack essential regulatory elements or have acquired disabling mutations such as premature stop codons or frameshifts. As such, pseudogenes like ubinuclein 1 pseudogene may be annotated in gene databases but do not serve as molecular targets in biological pathways, drug development, or therapeutic applications. They can sometimes be transcribed at low levels but typically have no known regulatory or disease-related roles, and their identification is important to avoid confusion in genetic studies and computational gene annotation.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubinuclein 1 pseudogene.